Cytrellis’ first product, ellacor, is a novel, proprietary system with Micro-Coring technology designed to remove excess skin associated with aging without invasive surgery or evidence of scarring.
Location: United States, Massachusetts, Woburn
Employees: 11-50
Phone: +1 857-254-1720
Total raised: $78.5M
Founded date: 2012
Investors 2
Date | Name | Website |
- | PFM Health... | pfmhealths... |
17.07.2021 | ARCH Ventu... | archventur... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
22.09.2021 | Series C | $50M | - | finsmes.co... |
05.06.2018 | Series B | $28.5M | - | citybizlis... |
Mentions in press and media 10
Date | Title | Description | Source |
22.09.2021 | Cytrellis Biosystems Closes $50M Series C Financing | Cytrellis Biosystems, a Woburn, Mass.-based medical technology company dedicated to the development ... | finsmes.co... |
21.09.2021 | Cytrellis Biosystems Nabs $50M Series C Round | WOBURN, MA, Cytrellis today announced the closing of a $50 million Series C funding round. >&g... | vcnewsdail... |
21.09.2021 | Why dealmaking in the sports betting and online gambling wor... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
21.09.2021 | Why dealmaking in the sports betting and online gambling wor... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
27.07.2021 | Cytrellis Announces FDA Clearance for Breakthrough ellacor™ ... | WOBURN, Mass., July 27, 2021 /PRNewswire/ -- Cytrellis announces that the U.S. Food and Drug Admin... | prnewswire... |
06.06.2018 | Term Sheet — Wednesday, June 6 | 5 Qs WITH A DEALMAKER Founders Fund partner Trae Stephens found his way to venture capital from the... | fortune.co... |
05.06.2018 | Cytrellis Biosystems Raises $28.5M in Series B Financing | Cytrellis Biosystems, Inc., a Woburn, Mass.-based medical technology company developing a new, propr... | finsmes.co... |
05.06.2018 | Cytrellis Biosystems Completes $28.5 Million Series B Financ... | Cytrellis Biosystems, Inc., a medical technology company developing a new, proprietary class of derm... | citybizlis... |
05.06.2018 | Cytrellis Biosystems Nabs $28.5M | WOBURN, MA, Cytrellis Biosystems today announced that it has received $28.5 million in a Series B ... | vcnewsdail... |
28.04.2016 | Cytrellis Biosystems Receives Strategic Venture Investment f... | Cytrellis Biosystems, a Boston, MA-based company developing a new class of non-surgical products to ... | finsmes.co... |